Announce Date | 06/05/2025 |
EPS Normalized Actual | $0.58 (Beat by $0.41) |
EPS GAAP Actual | $0.58 (Beat by $0.41) |
Revenue Actual | $0.821147B |
Revenue Surprise | Beat by $821.147M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Aug 2027 | 3.32 | 20.45 | 3.25818 | 3.36663 | 1 |
Jul 2027 | 4.81 | 14.12 | 4.77209 | 4.83995 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (May 2025) | 0.56 | 0.56 | 0.821147B | 0.49% | 821.15M |
FQ1 2025 (Jan 2025) | 1 | 1 | 0.949439B | 1.48% | 949.44M |
FQ4 2024 (Nov 2024) | 0.22 | 0.22 | 0.845089B | 2.51% | 845.09M |
FQ3 2024 (Jul 2024) | 0.82 | 0.82 | 0B | -INF% | 0M |
FQ2 2024 (Apr 2024) | -0.41 | -0.41 | 0.817135B | 100% | 817.14M |
FQ1 2024 (Jan 2024) | 0.0012 | 0.0012 | 0.935401B | 100% | 935.4M |
FQ4 2023 (Oct 2023) | 0.25 | 0.25 | 0.823839B | 100% | 823.84M |
FQ3 2023 (Jul 2023) | 1.69 | 1.69 | 0.836732B | 100% | 836.73M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Jul 2027) | 0.8252 | -- | 0.80788 | 0.84023 | 3 |
FQ2 2027 (Apr 2027) | 0.94202 | -- | 0.93228 | 0.95305 | 2 |
FQ1 2027 (Jan 2027) | 1.37951 | -- | 1.36525 | 1.39567 | 2 |
FQ4 2026 (Oct 2026) | 0.60374 | -- | 0.59107 | 0.61474 | 4 |
FQ3 2026 (Jul 2026) | 1.6613 | -- | 1.6613 | 1.6613 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Jul 2027) | 0.88B | -- | 0.86B | 0.89B | 4 |
FQ2 2027 (Apr 2027) | 0.88B | -- | 0.87B | 0.89B | 3 |
FQ1 2027 (Jan 2027) | 1B | -- | 0.99B | 1B | 3 |
FQ4 2026 (Oct 2026) | 0.87B | -- | 0.86B | 0.88B | 5 |
FQ3 2026 (Jul 2026) | 0.87B | -- | 0.87B | 0.87B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | 0.56 | 0.56 | 100% | |
FQ1 2025 (Jan 2025) | 1 | 1 | 100% | |
FQ4 2024 (Nov 2024) | 0.22 | 0.22 | 100% | |
FQ3 2024 (Jul 2024) | 0.82 | 0.82 | 100% | |
FQ2 2024 (Apr 2024) | -0.41 | -0.41 | 100% | |
FQ1 2024 (Jan 2024) | 0.0012 | 0.0012 | 100% | |
FQ4 2023 (Oct 2023) | 0.25 | 0.25 | 100% | |
FQ3 2023 (Jul 2023) | 1.69 | 1.69 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | $0B | $0.82B | $821.15M | 100% |
FQ1 2025 (Jan 2025) | $0B | $0.95B | $949.44M | 100% |
FQ4 2024 (Nov 2024) | $0B | $0.85B | $845.09M | 100% |
FQ3 2024 (Jul 2024) | $0B | $0B | $0M | NAN% |
FQ2 2024 (Apr 2024) | $0B | $0.82B | $817.14M | 100% |
FQ1 2024 (Jan 2024) | $0B | $0.94B | $935.4M | 100% |
FQ4 2023 (Oct 2023) | $0B | $0.82B | $823.84M | 100% |
FQ3 2023 (Jul 2023) | $0B | $0.84B | $836.73M | 100% |